Gene · 7486
Papers3,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential whole-genome doubling and homologous recombination deficiencies across breast cancer subtypes from the Taiwanese population. | Commun Biol | 2021 | 34504292 | PubTator, text mining | PubMed |
| Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy. | Stem Cell Res Ther | 2021 | 34503562 | PubTator, text mining | PubMed |
| Niraparib Suppresses Cholangiocarcinoma Tumor Growth by Inducing Oxidative and Replication Stress. | Cancers (Basel) | 2021 | 34503215 | PubTator, text mining | PubMed |
| Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma. | Comput Math Methods Med | 2021 | 34497663 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Detection of mobile elements insertions for routine clinical diagnostics in targeted sequencing data. | Mol Genet Genomic Med | 2021 | 34491624 | PubTator, text mining | PubMed |
| Profiling diverse sequence tandem repeats in colorectal cancer reveals co-occurrence of microsatellite and chromosomal instability involving Chromosome 8. | Genome Med | 2021 | 34488871 | PubTator, text mining | PubMed |
| Stable maintenance of the Mre11-Rad50-Nbs1 complex is sufficient to restore the DNA double-strand break response in cells lacking RecQL4 helicase activity. | J Biol Chem | 2021 | 34473993 | PubTator, text mining | PubMed |
| Author Correction: Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin A. | Sci Rep | 2021 | 34471172 | PubTator, text mining | PubMed |
| G-Quadruplex Assembly by Ribosomal DNA: Emerging Roles in Disease Pathogenesis and Cancer Biology. | Cytogenet Genome Res | 2021 | 34469893 | PubTator, text mining | PubMed |
| Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality. | Mol Cancer | 2021 | 34454516 | PubTator, text mining | PubMed |
| Lamin B1 sequesters 53BP1 to control its recruitment to DNA damage. | Sci Adv | 2021 | 34452908 | PubTator, text mining | PubMed |
| Bayer's Vividion Buy Targets Undruggable Proteins. | Cancer Discov | 2021 | 34446429 | PubTator, text mining | PubMed |
| Harnessing the Nucleolar DNA Damage Response in Cancer Therapy. | Genes (Basel) | 2021 | 34440328 | PubTator, text mining | PubMed |
| Crosstalk among DNA Damage, Mitochondrial Dysfunction, Impaired Mitophagy, Stem Cell Attrition, and Senescence in the Accelerated Ageing Disorder Werner Syndrome. | Cytogenet Genome Res | 2021 | 34433164 | PubTator, text mining | PubMed |
| Fast mutual exclusivity algorithm nominates potential synthetic lethal gene pairs through brute force matrix product computations. | Comput Struct Biotechnol J | 2021 | 34429855 | PubTator, text mining | PubMed |
| Predicting and characterizing a cancer dependency map of tumors with deep learning. | Sci Adv | 2021 | 34417181 | PubTator, text mining | PubMed |
| Brainstem intraparenchymal schwannoma with genetic analysis: a case report and literature review. | BMC Med Genomics | 2021 | 34407809 | PubTator, text mining | PubMed |
| Phosphorylation of PUF-A/PUM3 on Y259 modulates PUF-A stability and cell proliferation. | PLoS One | 2021 | 34407138 | PubTator, text mining | PubMed |
| Characterization of Histone Deacetylase Mechanisms in Cancer Development. | Front Oncol | 2021 | 34395273 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7486/papers?page=41